Followers | 14 |
Posts | 230 |
Boards Moderated | 0 |
Alias Born | 09/24/2021 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 28, 2021 9:16:00 AM
All agreements with IMMB BG were cancelled for failure to perform. The only license that is in place is the license granting exclusive rights to the patent to ENZC- including manufacturing rights.
Based on this license agreement between the Trust and ENZC, two distribution agreements have been entered into in 20021; one to the IMPL entity, which is paying for the clinical trials and EMA permitting cost and ENZC owns 50% and a second with an entity that is contributing 50% of a manufacturing facility in Bulgaria once the permit from the EMA is completed. I am sure neither of these two seasoned groups would have invested in a distributorship if there were any other license of the ITV-1 immunotherapy.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM